A Curated Platform of Equity & Options Market Intelligence
Select Page

ABUS

Search by
TICKER SYMBOL

Arbutus Biopharma Corp

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

3.1

0.1

(3.333%)

Volume:

479,296

52 week range:

1.85 - 3.22

Market Cap:

503.97M

Company Description:

Arbutus Biopharma Corporation is a biopharmaceutical company primarily dedicated to discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection. The Company is advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery and development effort for treating coronaviruses (including COVID-19).